Kosowicz J, Horst-Sikorska W, Lacka K
Kliniki Endokrynologii I. Ch. W. Akademii Medycznej, Poznaniu.
Pol Tyg Lek. 1993;48(27-28):599-602.
The results of hypothyreosis therapy with thyroideum (dried thyroid gland) were assessed in 40 patients. The study aimed at establishing proper dosage and assaying blood serum T4, T3, and TSH levels. Daily dose of 1 tablet (0.2 mg of iodine) improved clinical status but did not cover the daily requirement of the body for thyroid hormones. An increase in daily dose to 2 tablets (0.4 mg of iodine) produced nearly complete compensation of hypothyreosis. However, such a daily dose was often associated with adverse reactions, especially in patients with arterial hypertension or atherosclerosis. Thyroid hormones assay has shown that dried thyroid gland administered in daily dose of 0.4 mg normalizes serum T3 levels whereas serum T3 levels remained constantly low, and TSH increased as in non-treated disease. An increase of the daily dose to 0.6 mg of iodine produces excessive increase in serum T3 levels with clinical symptoms of T3 toxicity.
对40例甲状腺功能减退症患者采用甲状腺片(干甲状腺)进行治疗,并对治疗结果进行了评估。该研究旨在确定合适的剂量,并检测血清T4、T3和TSH水平。每日服用1片(含碘0.2毫克)可改善临床症状,但未满足机体对甲状腺激素的每日需求。将每日剂量增加至2片(含碘0.4毫克)可使甲状腺功能减退症几乎完全得到代偿。然而,这样的每日剂量常伴有不良反应,尤其是在患有动脉高血压或动脉粥样硬化的患者中。甲状腺激素检测表明,每日服用0.4毫克干甲状腺可使血清T3水平恢复正常,而血清TSH水平仍持续偏低,且与未治疗疾病时一样升高。将每日剂量增加至含碘0.6毫克会使血清T3水平过度升高,并出现T3中毒的临床症状。